Dale Broadrick - 07 Feb 2024 Form 4 Insider Report for BioRestorative Therapies, Inc. (BRTX)

Role
10%+ Owner
Signature
/s/ Dale Broadrick
Issuer symbol
BRTX
Transactions as of
07 Feb 2024
Net transactions value
+$162,255
Form type
4
Filing time
09 Feb 2024, 08:00:31 UTC
Previous filing
05 Dec 2023
Next filing
12 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BRTX Common Stock Purchase $50,196 +36,374 +11% $1.38 363,419 07 Feb 2024 Direct
transaction BRTX Common Stock Purchase $112,059 +83,626 +23% $1.34 447,045 08 Feb 2024 Direct
holding BRTX Common Stock 317,972 07 Feb 2024 See Footnote F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding BRTX Warrant to acquire Common Stock 250 07 Feb 2024 Common Stock 250 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 276 07 Feb 2024 Common Stock 276 $120.00 Direct
holding BRTX Warrant to acquire Common Stock 833 07 Feb 2024 Common Stock 833 $120.00 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Owned by Fleetco, Inc. of which the reporting person is a 93% shareholder.